EBITDA

A $1.9M real estate deal for a Pennsylvania vet clinic reveals how UPREIT exchanges help practice owners unlock capital tax-efficiently while securing care.

A new partnership embeds AI directly into EHRs to automate prior authorizations, aiming to slash physician burnout and get patients medicine faster.

Experian's new 'BFF' campaign with Fred Warner and Puka Nacua aims to make you the MVP of your finances. But does the star power deliver real value?

RELEX Solutions' strategic acquisition of Ida aims to revolutionize fresh food management, promising less waste, higher sales, and a smarter supply chain.

A major partnership brings high-tech, locally grown organic herbs to Mid-Atlantic shelves, aiming to slash food miles and redefine retail freshness.

A new partnership between DoControl and Sentra promises to turn data insights into automated security, closing a critical gap in SaaS data protection.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

Belgian metals giant Campine invests in advanced antimony recycling and moves to continuous trading, navigating a volatile market with record-breaking earnings.

ICL Group's deal to acquire acidulant leader Bartek Ingredients signals a major push into the booming functional food market, leveraging unique production.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Vision Marine secures critical funds for its electric boat ambitions, but the deal's terms raise questions about shareholder value and its financial health.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

IonQ and QuantumBasel expand their partnership to over $60M, aiming to unlock practical quantum solutions for AI, pharma, and logistics across Europe.

As air traffic control migrates to VoIP, new testing solutions ensure the reliability and interoperability crucial for preventing communication failures.

Incyte's Minjuvi, a first-of-its-kind immunotherapy, gains EC approval for follicular lymphoma, offering patients a powerful new chemo-free option.

North America's largest private homebuilder completes a major refinancing, bolstering its balance sheet for growth amid a turbulent housing market.